ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Infectious Disease

Top Infectious Disease Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PATRICIA BARNWELL M.D.

Infectious Disease

7,633

$550K

272
230 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 44%

$72
Average prescription price

Avg: $280

INSKI HOWARD YU MD

Infectious Disease

7,369

$360K

429
308 are 65+

18%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 44%

$49
Average prescription price

Avg: $280

PAULINE LETT-ANDERSON M.D.

Infectious Disease

6,733

$370K

568
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 44%

$55
Average prescription price

Avg: $280

ANUPAMA RAGHURAM M.D.

Infectious Disease

3,836

$227K

183
127 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 44%

$59
Average prescription price

Avg: $280

ANITA FLEENOR-FORD MD

Infectious Disease

2,944

$1.25M

134
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 44%

$423
Average prescription price

Avg: $280

RICHARD GREENBERG MD

Infectious Disease

2,505

$1.31M

83
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 44%

$521
Average prescription price

Avg: $280

CARL LEBUHN M.D.

Infectious Disease

2,477

$1.1M

155
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 44%

$445
Average prescription price

Avg: $280

CECILIA GAYNOR M.D.

Infectious Disease

1,978

$888K

202
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 44%

$449
Average prescription price

Avg: $280

RAMA KAPOOR M.D

Infectious Disease

1,977

$1.15M

121
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 44%

$580
Average prescription price

Avg: $280

ALICE THORNTON MD

Infectious Disease

1,703

$1.22M

100
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 44%

$714
Average prescription price

Avg: $280

JOHN MEEK MD

Infectious Disease

1,480

$334K

264
147 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 44%

$226
Average prescription price

Avg: $280

BARBARA WOJDA M.D.

Infectious Disease

1,469

$951K

121
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 44%

$647
Average prescription price

Avg: $280

MARK DOUGHERTY MD

Infectious Disease

916

$264K

164
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 44%

$288
Average prescription price

Avg: $280

RAUL NAKAMATSU MD

Infectious Disease

908

$559K

36
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 44%

$616
Average prescription price

Avg: $280

FOREST ARNOLD DO

Infectious Disease

867

$487K

51
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 44%

$562
Average prescription price

Avg: $280

DORA SAVANI MD

Infectious Disease

834

$386K

52
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 44%

$463
Average prescription price

Avg: $280

MICHAEL YOUNG MD

Infectious Disease

815

$278K

86
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 44%

$342
Average prescription price

Avg: $280

MARTY ALLEN M.D.

Infectious Disease

784

$120K

124
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 44%

$153
Average prescription price

Avg: $280

CHARLES ROSE

Infectious Disease

776

$137K

175
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 44%

$176
Average prescription price

Avg: $280

THEIN MYINT M.D

Infectious Disease

738

$545K

67
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 44%

$739
Average prescription price

Avg: $280

TARIQ MEHMOOD MD

Infectious Disease

711

$335K

148
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 44%

$471
Average prescription price

Avg: $280

DANIEL RODRIGUE MD

Infectious Disease

697

$273K

143
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 44%

$392
Average prescription price

Avg: $280

KAMRAN AKHTAR MD

Infectious Disease

682

$293K

103
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 44%

$429
Average prescription price

Avg: $280

JULIO MELO MD

Infectious Disease

590

$160K

102
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 44%

$271
Average prescription price

Avg: $280

CHARLES KENNEDY MD

Infectious Disease

576

$145K

121
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 44%

$252
Average prescription price

Avg: $280

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank